10% Owner · InMed Pharmaceuticals Inc. · Common Shares
Side
BUY
Value
$35K
Shares
2,640
Price
$13.1
Executed
Nov 5, 2026
Disclosed
Nov 9, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 5 executedNov 9, 2026 disclosed
MTRI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 15 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ADAR1 Capital Management, LLC filed this Form 4 reporting a open-market purchase of MTRI on Nov 5, 2026. It became public on Nov 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
10% Owner
ADAR1 Capital Management, LLCcik:0001940272
Issuer
InMed Pharmaceuticals Inc.cik:0001728328
Revision history · 0
No field has changed since this record was first ingested.
